- $50.68bn
- $58.10bn
- $129.66bn
'Cut points' for 2027 Medicare Advantage plans look neutral to positive, analysts say
Brief: Thyme Care Closes Series E Financing Round Of Over $125 Million
Brief: Soros Cuts Stake in Amazon, Uber; Raises in Apple, Broadcom
Humana agrees not to reference Teva's Israel ties at US drug trial
Brief: Humana Healthy Horizons In Indiana Collaborates With Healthstream To Expand And Strengthen Home Care Workforce
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
Teva seeks to keep Israel ties from jury, cites Gaza war
Wall Street warms to healthcare stocks as tech trade faces turbulence
U.S. STOCKS ON THE MOVE-Mondelez, IDEX, Merchants Bancorp
U.S. STOCKS ON THE MOVE-Mondelez, IDEX, Merchants Bancorp
Humana falls as unchanged annual profit forecast overshadows Q2 beat
U.S. STOCKS ON THE MOVE-Ford, GE, P&G
U.S. STOCKS ON THE MOVE-Seagate, Bloom Energy, Generac
Humana Inc reports results for the quarter ended June 30 - Earnings Summary
Humana Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Humana Third Quarter Insurance Segment Benefit Ratio Expected To Be Slightly Above 94% - Prepared Remarks
Humana falls as unchanged annual profit forecast overshadows Q2 beat
Humana leaves annual adjusted profit outlook unchanged, shares drop (updated)
Corrected: Humana beats Q2 adjusted EPS estimates, affirms FY adjusted EPS guidance